RxDoctor Payments Data

Yoseph Shalev, MD

Interventional Cardiology · Lewisburg, WVNPI 1821065467

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) at 56.7% of the total. Reporting peaked in 2024 at $145 and has fallen 52.9% since, to $68 in 2025. That places this record below the midpoint for interventional cardiology clinicians in WV, where the typical reported total is $7,222.

$336in general payments, 2019–2025

Across 12 payments — averaging $28.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$191
  • Medtronic$76
  • Bracco Diagnostics Inc.$23
  • Lantheus Medical Imaging, Inc.$18
  • Boston Scientific$15
  • AstraZeneca$14

What the payments were for

  • Food & beverage$336100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$336 in reported general payments places this provider in the 10th percentile of 46 interventional cardiology providers in West Virginia.

See all interventional cardiology providers in West Virginia

Medicare billing

Part B allowed, 2024
$115,181
Medicare patients
1,622
Services billed
3,662

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban200$167,248
EntrestoSacubitril/Valsartan133$125,294
XareltoRivaroxaban18$15,357
JardianceEmpagliflozin15$11,577
Flecainide Acetate257$6,044
Midodrine Hcl51$4,539
Metoprolol Succinate270$2,240
Diltiazem 24hr Er (Cd)Diltiazem Hcl133$1,621
Bisoprolol Fumarate72$925
Ezetimibe20$904
Carvedilol162$853
Amiodarone Hcl62$756
Metoprolol Tartrate119$595
Digoxin34$467
Lisinopril125$465

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Lewisburg

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →